Inventor · disambiguated record
Everardus Orlemans
Also filed as: ORLEMANS EVERARDUS · ORLEMANS EVERARDUS O · ORLEMANS EVERARDUS O M
4 granted patents·6 pending applications·447 citations·filing 2009–2017
85Inventor score
Top patents by PatentIndex Score
10 records- 0197US9801824B2Method for delivering a pharmaceutical composition to patient in need thereofPOZEN INC·Filed 2016·Granted Oct 31, 2017·110 cites·20 claims
- 0297US9393208B2Method for delivering a pharmaceutical composition to patient in need thereofPOZEN INC·Filed 2015·Granted Jul 19, 2016·113 cites·7 claims
- 0395US9220698B2Method for delivering a pharmaceutical composition to patient in need thereofAULT BRIAN·Filed 2009·Granted Dec 29, 2015·114 cites·7 claims
- 0494US8945621B2Method for treating a patient at risk for developing an NSAID-associated ulcerAULT BRIAN·Filed 2010·Granted Feb 3, 2015·110 cites·16 claims
- 0547US2016166558A1Method for treating a patient at risk for developing an nsaid-associated ulcerPOZEN INC·Filed 2016·Application pending·0 cites
- 0644US2015202193A1Method for treating a patient at risk for developing an nsaid-associated ulcerPOZEN INC·Filed 2015·Application pending·0 cites
- 0740US2019134003A1Combination therapies using indazolylbenzamide derivatives for the treatment of cancerESANEX INC·Filed 2017·Application pending·0 cites
- 0838US2015328188A1Combination Therapies for the Treatment of Proliferative DisordersORLEMANS EVERARDUS O·Filed 2015·Application pending·0 cites
- 0936US2019269656A1Combination Therapies Using Indazolylbenzamide Derivatives for the Treatment of CancerESANEX INC·Filed 2017·Application pending·0 cites
- 1029US2016143884A1Use of tetrahydroindazolylbenzamide and tetrahydroindolylbenzamide derivatives for the treatment of human immunodeficiency virus (hiv) and acquired immune deficiency syndrome (aids)ESANEX INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Everardus Orlemans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →